Biblio Discovery — Demo Discovery Service

1 results for "Maya DIMITROVA"

Showing 1–1 · 1.30 seconds · RSS

  1. Journal Article Full text

    Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma

    James Randall Patrinely; Rebecca R Johnson; Aleigha R. Lawless et al.

    JAMA Oncology · 2021 · English · OpenAlex Scopus

    Importance: Agents targeting programmed cell death 1 (PD-1)/PD ligand 1 (PD-L1) improve long-term survival across many advanced cancers and are now used as adjuvant therapy for resected stage III and IV melanomas. The incidence and spectrum of chronic immune-related adverse events (irAEs) have not…